Guang-Yu Yang

  • 8823 Citations
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Surgical Pathology

The long-term objective of our research is to study molecular mechanism and chemoprevention of chronic inflammation-driven carcinogenesis. The specific areas of interest are 1) to develop a molecular mimicking model of ulcerative colitis-associated carcinogenesis in rodents, and further to elucidate the role of inflammation-caused and dietary iron-enhanced nitro-oxidative stress and inflammatory mediators in DNA damage, cell proliferation and inflammation-driven carcinogenesis; 2) to study the pathogenesis and molecular biomarkers of pancreatic carcinoma in genetically engineered mouse model and in human; and 3) to develop an efficient strategy on the prevention of chronic inflammation-driven carcinogenesis, particularly interested in dietary nutrients, antioxidants, green tea and inositol compounds and specifically targeted on colorectal, pancreatic, and liver carcinogenesis.

Certifications and Licenses

Anatomic Pathology & Clinical Pathology

Training Experience

2004Residency, New York University Medical Center
2005Fellowship, Johns Hopkins Hospital

Education/Academic qualification

PhD, China Medical University

… → 1992

MD, China Medical University

… → 1983

Research interests

  • Cancer Biology
  • Inflammatory Bowel Disease
  • Liver Disease / Pathobiology
  • Pancreatic Disorders
  • Pathology
  • Digestive Cancer (esophagus, stomach, colon, rectum)

Fingerprint Dive into the research topics where Guang-Yu Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

  • Research Output

    Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

    Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), Jan 2020, In : Journal of Allergy and Clinical Immunology. 145, 1, p. 28-37 10 p.

    Research output: Contribution to journalArticle

  • A phase I trial of berberine in Chinese with ulcerative colitis

    Xu, L., Zhang, Y., Xue, X., Liu, J., Li, Z. S., Yang, G. Y., Song, Y., Pan, Y., Ma, Y., Hu, S., Wen, A., Jia, Y., Rodriguez, L. M., Tull, M. B., Benante, K., Khan, S. A., Cao, Y., Jovanovic, B., Richmond, E., Umar, A. & 2 others, Bergan, R. & Wu, K., Jan 1 2020, In : Cancer Prevention Research. 13, 1, p. 117-126 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort

    Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), Jun 2020, In : Journal of Allergy and Clinical Immunology. 145, 6, p. 1629-1640.e4

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study

    Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), Jan 2020, In : Journal of Allergy and Clinical Immunology. 145, 1, p. 255-269 15 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations